Fruits rich in phytochemicals have been shown to improve memory by protecting or enhancing neuronal functions mediated by neurotrophic factors, such as nerve growth factor (NGF), in the hippocampus. Mori Fructus (Morus alba L., Moraceae), also called mulberry, is used as a food, dietary supplement and an anti-ageing agent in traditional Oriental medicine. It is also known to contain abundant flavonoid compounds and to exhibit various pharmacological effects. The present study was performed to evaluate the memory-enhancing effect of Mori Fructus extract (ME) in mice, with a focus on NGF regulation. ME (20, 100 and 500 mg/kg per d for 7 d, per os) dose-dependently promoted NGF release in the mouse hippocampus, leading to phosphorylation of extracellular signal-regulated kinases and cyclic AMP response element-binding protein. ME significantly increased pre-and post-synapse formation, acetylcholine synthesisation, neuronal cell differentiation, neurite outgrowth and neuronal cell proliferation in the mouse hippocampus. Furthermore, ME significantly increased latency time in the passive avoidance task (P,0·001) and recognition time of novel objects in the object recognition test (P, 0·05), indicating improvements in learning and memory. Taken together, these data suggest that ME exhibits a memory-enhancing effect via up-regulation of NGF.
Nerve growth factor (NGF) was the first identified and is the best-characterised member of the neurotrophic family, which consists of polypeptide growth factors. NGF influences the proliferation, differentiation, survival and death of cholinergic neurons in the central nervous system (1, 2) . As cholinergic neurons projecting to the hippocampus are believed to be important for memory processes (3) , NGF is considered a therapeutic target for dementia, including Alzheimer's disease (2) .
However, NGF is a high-molecular-weight polypeptide that cannot penetrate the blood -brain barrier; thus, its use requires neurosurgery (4) . Therefore, small molecules that can readily cross the blood -brain barrier to activate receptors or potentiate the actions of NGF are required (5) . For example, partial improvements of cognitive function in Alzheimer's disease patients have been reported with intraventricular injection of NGF protein and intravenous infusion of low-molecular-weight neuropeptides and NGF agonists to increase NGF levels (6) . Mori Fructus (mulberry) is the fruit of Morus alba L., of the Moraceae family. It is easily grown, cultivated worldwide and is commonly eaten as a dessert, juice, wine and vinegar. Nutritionally, Mori Fructus contains fats (1·10 %), fatty acids such as linoleic acid, palmitic acid and oleic acid, vitamin C (22·4 mg/100 g), minerals, phenolics (181 mg gallic acid equivalents/100 g) and flavonoids (29·0 mg quercetin equivalents/100 g) (7) . In traditional Oriental medicine, it has been used as an anti-ageing agent thought to act via generation of body fluids (8) . Mori Fructus has been shown to have various phytoconstituents with multi-bioactive functions. For example, anthocyanins, a subset of the flavonoids, are present in small berries, including the mulberry, and have antioxidant, anti-inflammatory and anti-cancer activities (9) . Moreover, they can cross the blood -brain barrier and modulate several cellular processes in the brain (10, 11) . Thus, there is a great deal of interest in the potential of flavonoids with regard to neuronal function and prevention of age-related neurodegeneration (11) , by protecting neurons, enhancing neuronal function or stimulating neurotrophins (12) . Previous studies showed that Mori Fructus has various biological effects, such as antioxidant, anti-inflammatory, anti-cancer, anti-obesity and hypolipidaemic activities, due to its various phytochemical constituents (9,13 -15) . In addition, neuro-associated actions of Mori Fructus have been reported to include an anti-stress effect (16) . Furthermore, it exhibited a neuroprotective effect in a cerebral ischaemia mouse model (17) , a senescence-accelerated cognitive deficiency mouse model (18) and a Parkinson's disease model (15) . Moreover, a constituent of Mori Fructus, cyanidin-3-O-b-glucopyranoside, reverses ethanol-induced inhibition of neurite outgrowth by inactivating glycogen synthase kinase 3b (19) .
Although various neuro-associated actions of Mori Fructus extract (ME) have been reported, the effect of ME on memory has not yet been investigated. In the present study, we evaluated the memory-enhancing effect of ME, with a focus on NGF regulation, and investigated various NGF signalling events that regulate synaptic plasticity, acetylcholine (ACh) synthesisation, neuronal survival and cognitive performance.
Materials and methods

Materials
Rat monoclonal anti-5-bromo-2-deoxyuridine (BrdU), rabbit monoclonal anti-phosphorylated extracellular signal-regulated kinase (pERK), rabbit monoclonal anti-phosphorylated cyclic AMP response element-binding protein (pCREB), rabbit monoclonal anti-ERK, rabbit monoclonal anti-CREB and goat polyclonal anti-doublecortin (DCX) were purchased from Santa Cruz Biotechnology, Inc. Rabbit polyclonal anti-post-synaptic density-95 (PSD95) was purchased from Abcam. Biotinylated rabbit anti-rat antibody, horse anti-goat antibody, goat anti-rabbit antibody and avidin -biotin complex were purchased from Vector Laboratory. 3-(4,5-Dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide, chlorogenic acid, caffeic acid, ferulic acid, cinnamic acid, glucose, dimethyl sulphoxide, paraformaldehyde, 3,3-diaminobenzidine, NaCl, sucrose, ethanol, PBS, HCl, formamide, 20 £ standard saline -citrate buffer, nickel chloride hexahydrate (NiCl 2 ), phosphatase inhibitor cocktail, BrdU and mouse monoclonal anti-synaptophysin (SYN) were purchased from Sigma-Aldrich. Tetramethylethylenediamine, protein assay reagent, Tween 20, ammonium persulphate, acrylamide, enhanced chemiluminescence Western blotting detection reagent and skimmed milk were purchased from Bio-Rad Laboratory. Anti-rabbit and mouse-horseradish peroxidase secondary antibodies were purchased from Assay Designs, Inc. ChemiKinee NGF sandwich ELISA kit and goat polyclonal anti-choline acetyltransferase (ChAT) were purchased from Chemicon International, Inc.
Preparation of extract and quantification of phenolic acids
The extract of dried mulberry fruit (ME) was the same as that used in a previous study (15) in which chemical profiling and standardisation of ME had been performed. Briefly, dried mulberry fruit was cultivated in Yeongcheon-si (Gyeongsangbukdo, South Korea), purchased from Jung Do Herbal Drug Company and was extracted with 70 % ethanol for 24 h at room temperature. Then, the extract was filtered, evaporated on a rotary vacuum evaporator and finally lyophilised. The powder (yield, 20·53 %) was kept at 48C. ME was standardised based on the concentration of cyanidin-3-O-b-glucopyranoside, and as a result, the content of cyanidin-3-O-b-glucopyranoside in ME was 0·43 (SD 0·02) mg/g.
In addition, we quantified phenolic acids in ME based on the contents of chlorogenic acid, caffeic acid, ferulic acid and cinnamic acid using reverse-phase HPLC (PerkinElmer 200 HPLC system; PerkinElmer, Inc.) equipped with a photodiode array detector. Separation was carried out using a Shiseido Capcellpak C18 column (250 £ 4·6 mm, 5 mm; Shiseido Co., Ltd) at 258C. The injection volume was 10 ml. The mobile phases (A: 0·1 % acetic acid in methanol and B: 0·1 % acetic acid in water) were 10 -10 % A for 0 -10 min; 10 -25 % A for 10 -15 min; 25 -35 % A for 15-25 min; 35 -50 % A for 25 -35 min; 50 -95 % A for 35 -45 min; and 95 -10 % A for 45 -60 min at a flow rate of 1 ml/min. The detector wavelength was set at 280 nm. Four concentrations of chlorogenic acid, caffeic acid, ferulic acid and cinnamic acid were prepared at 1, 2·5, 5 and 10 mg/ml, where 10 ml was injected as external standard. References to the calibration curve obtained with those four external standards and ME were analysed in triplicates. Chlorogenic acid, caffeic acid, ferulic acid and cinnamic acid were found in ME at mean levels of 2·43 (SD 0·12), 1·59 (SD 0·12), 0·21 (SD 0·06) and 0·04 (SD 0·00) mg/g, respectively. Before each experiment, the extract was dissolved in an appropriate vehicle and was vortex mixed for 2 min at room temperature.
Animals and treatment
Animal treatment and maintenance were carried out in accordance with the Principle of Laboratory Animal Care (National Institutes of Health publication no. 85-23, revised 1985) and the Animal Care and Use Guidelines of Kyung Hee University, Seoul, South Korea. Male ICR mice (outbred, albino, 6 weeks, 25 -28 g) were purchased from Daehan Biolink Company Limited. Animals were housed five per cage, had free access to water and food and maintained under a constant temperature (23^18C), humidity (60^10 %) and a 12 h light -12 h dark cycle. The mice were randomly divided into four groups (n 10 in each group): (1) a vehicle-treated group (control group); (2) a 20 mg/kg per d ME-treated group; (3) a 100 mg/kg per d ME-treated group; and (4) a 500 mg/kg per d ME-treated group. ME was dissolved in normal saline with 10 % dimethyl sulphoxide and administered orally once per d for 7 d. The orally administered doses of ME were derived from the previous report and chosen from the lower doses of it (14) . The control group was administered with an equal Memory-enhancing effect of Mori Fructusvolume of saline with 10 % dimethyl sulphoxide. Independently of drug treatment, BrdU, a thymidine analogue, which incorporates into the DNA of dividing cells during the S phase of the cell cycle, was used to label the dividing cells (20) . Mice were intraperitoneally injected with BrdU (50 mg/kg) three times at 3 h intervals on the day before they were killed for the preparation of brain tissues, as described elsewhere (21) , with minor modification.
The step-through passive avoidance test
On day 7 of ME treatment, learning and memory were evaluated using a two-compartment step-through passive avoidance apparatus, according to the method described previously (3) . A box was divided into bright (21 £ 21 £ 21 cm) and dark (21 £ 21 £ 21 cm) compartments by a guillotine door. The bright compartment contained a 50 W electric lamp, while the floor of the dark compartment consisted of 2 mm stainless steel rods spaced 1 cm apart. Final administrations were performed 1 h before the acquisition trial. Each mouse was placed in the bright compartment, and the door separating the two compartments was opened 10 s later. Then, after the mouse fully entered the dark chamber, the guillotine door closed and an electrical foot shock (0·1 mA/ 10 g) was delivered through the grid floor for 3 s. At 24 h after the acquisition trial, each mouse was placed in the bright chamber for a retention trial. Latency was defined as the time it took for a mouse to enter the dark chamber after the door opened. Latency time was recorded for up to 600 s.
Object recognition test
The experiments were carried out on day 7 of ME treatment. Prior to the test, mice were habituated to the test box, a black open field box (45 £ 45 £ 50 cm), for 5 min without objects. After a habituation period, mice were placed into the test box with two identical objects and allowed to explore for 3 min. The objects used in the present study were wooden blocks of the same size but different shape. The time spent by the animal exploring each object was measured (defined as the training session). At 24 h after the training session, mice were allowed to explore the objects for 3 min, in which one familiar object used in the previous training session was placed with a novel object. The time that the animals spent exploring the novel and the familiar objects were recorded (defined as the test session). The animals were regarded to be exploring when they were facing, sniffing or biting the object. The test box and objects were cleaned with 70 % ethanol between sessions. Results were expressed as percentage of novel object recognition time:
Time percentage ¼ t novel=ð t novel þ t familiarÞ £ 100:
Brain tissue preparation
At 24 h after the BrdU injection, mice were immediately anaesthetised using a mixture of Zoletil 50 and Rompun solution (3:1 ratio, 1 ml/kg, intraperitoneally), perfused transcardially with 0·05 M-PBS and then fixed with cold 4 % paraformaldehyde in 0·1 M-phosphate buffer. Brains were removed and post-fixed in 0·1 M-phosphate buffer containing 4 % paraformaldehyde overnight at 48C and then immersed in a solution containing 30 % sucrose in 0·05 M-PBS for cryoprotection. Serial 30 mm-thick coronal sections were cut on a freezing microtome (Leica) and stored in cryoprotectant (25 % ethylene glycol, 25 % glycerol and 0·05 M-phosphate buffer) at 48C until use for immunohistochemistry. For NGF ELISA assay and Western blotting, mice were decapitated and their brains were rapidly excised. Hippocampus tissues were stored at 2 708C until performing NGF ELISA kit assay and Western blotting.
Nerve growth factor ELISA assay
Total NGF levels were detected using the NGF sandwich ELISA kit, according to the instruction manual. Briefly, hippocampus tissues were homogenised in ice-cold homogenisation buffer and centrifuged at 14 000 g for 30 min at 48C. The resulting supernatants were used for the assay. Standards and tissue samples were incubated with a sheep anti-mouse NGF polyclonal antibody-pre-coated ninety-six-well immunoplate overnight at 48C. The plate was washed at least four times and incubated with anti-mouse NGF monoclonal antibody (1:100 dilution) for 2 h at room temperature. After washing, the plate was incubated with donkey anti-mouse IgG polyclonal antibody (1:1000 dilution) for 2 h at room temperature. The plate was incubated with 3,3',5,5'-tetramethylbenzidine/ ELISA substrate for 10 min and a stop solution was added to each well. The plate was read at 450 nm by using a spectrophotometer (Versamax microplate reader; Molecular Device), and concentrations of NGF were determined in the sample solution using a NGF standard calibration curve. Protein from the samples was normalised by using the Bio-Rad assay for total protein determination.
Immunohistochemistry
For immunohistochemical detection of BrdU, brain sections were pretreated with 50 % formamide in 2 £ standard saline -citrate buffer at 658C for 2 h before being incubated at 378C for 30 min in 2 M-HCl. The sections were then rinsed for 10 min at 258C in 0·1 M-boric acid (pH 8·5). Brain sections were briefly rinsed in PBS buffer and treated with 1 % H 2 O 2 for 15 min. The sections were incubated with rat anti-BrdU antibody (1:500 dilution) overnight at 48C in the presence of 0·3 % Triton X-100 and 3 % normal horse serum. After rinsing in PBS buffer, the sections were then incubated with biotinylated anti-rat IgG (1:200 dilution) for 90 min and then with avidin -biotin complex (1:100 dilution) for 1 h at room temperature. Peroxidase activity was visualised by incubating sections with nickel-3,3-diaminobenzidine in 0·05 M-Tris-buffered saline (pH 7·6). For the immunohistochemical study of DCX, brain sections were incubated overnight at room temperature with goat anti-DCX antibody (1:500 dilution). Then, the sections were incubated with secondary antibody following the same procedures as for BrdU. Peroxidase activity was visualised by incubating sections with 3,3-diaminobenzidine in Tris-buffered saline. After several rinses with PBS, sections were mounted on gelatin-coated slices, dehydrated and coverslipped with a histomount medium. The number of BrdU-and DCX-immunoreactive cells and the neurite length in the dentate gyrus (DG) of hippocampus were estimated by measuring at 200 £ magnification using an AnalySIS LS Research (Soft Imaging System Limited). The numbers of cells or the lengths of dendrites were measured in six sections per animal by a person blind to the treatment group, and the average per section was computed. The images were photographed at 200 £ magnification using an optical light microscope (Olympus Microscope System BX51; Olympus) equipped with a 20 £ objective lens. Data are presented as percentages of control group values.
Western blotting
The brain tissues were lysed with a triple-detergent lysis buffer to detect pERK, pCREB, SYN, PSD95 and ChAT according to the manufacturer's instructions. The lysates were separated by 12 or 10 % SDS-PAGE and then transferred to a membrane. Membranes were incubated with 5 % skimmed milk in Trisbuffered saline and Tween 20 for 1 h and then with the primary antibodies (1:5000 dilution of pERK, ERK, pCREB and CREB; 1:500 dilution of SYN and ChAT; 1:2000 dilution of PSD95 and b-actin) overnight at 48C, followed by incubation with horseradish peroxidase-conjugated secondary antibodies for 1 h. Immunoreactive bands were detected using an enhanced chemiluminescence detection kit, and a LAS-4000 mini system (Fujifilm Corporation) was used for visualisation. The intensities of the bands were normalised to the non-phospho-form band or b-actin band using Multi Gauge software (Fujifilm Corporation).
Statistical analysis
All quantitative data were analysed. The results are expressed as means and standard deviations for phenolic contents or standard errors of the mean for others. Statistical significance was determined by one-way ANOVA followed by Tukey's post hoc test using GraphPad Prism 4.0 software (GraphPad Software Inc.). P values less than 0·05 were deemed to be statistically significant.
Results
Effects of Mori Fructus extract on up-regulation of nerve growth factor in the mouse hippocampus
To investigate the effects of ME on NGF production in the mouse hippocampus, we performed the NGF ELISA kit assay. In our preliminary study, 100 mg/ml ME treatment for 24 h in C6 glioma cells showed NGF increase up to 122 % compared with the control group (100 %) and no significant cell toxicity was observed (data not shown). Thus, the NGFinducing effect of ME was confirmed in the mouse hippocampus after 7 d of ME treatment. NGF concentration was 333 (SEM 11·1), 441 (SEM 2·04) and 478 (SEM 19·2) pg/mg protein in the mouse hippocampus after ME treatment of 20, 100 and 500 mg/kg per d, respectively, compared with the control group (314 (SEM 0·29) pg/mg protein). The maximal effect was shown at 500 mg/kg per d of ME treatment (Fig. 1) . Therefore, these results suggest that ME acts as an NGF inducer.
Effects of Mori Fructus extract on phosphorylation of extracellular signal-regulated kinase and cyclic AMP response element-binding protein in the mouse hippocampus
To evaluate the effects of ME on pERK and pCREB elevations, which were stimulated by NGF in the adult hippocampus (22) , Western blotting was performed using the mouse hippocampus. pERK/ERK expression level was elevated to 159 (SEM 7·45), 182 (SEM 11·9) and 321 (SEM 19·9) % in the ME treatment groups at 20, 100 and 500 mg/kg per d, respectively, compared with the control group ( Fig. 2(a) ). CREB, a transcription factor, is activated downstream of ERK and is a key signalling molecule involved in learning and memory (23) . pCREB/CREB expression level was elevated to 150 (SEM 17·8), 182 (SEM 0·47) and 353 (SEM 13·5) % at 20, 100 and 500 mg/kg per d of ME treatment, respectively, compared with the control group ( Fig. 2(b) ). Thus, we found that inducing effect of ME on NGF production resulted in phosphorylation of ERK and CREB.
Effects of Mori Fructus extract on synaptic formation and acetylcholine synthesisation in the mouse hippocampus
To investigate the effects of ME on the pre-and post-synaptic density in the hippocampus, SYN and PSD95 expression levels were analysed, respectively, in brain tissue. CREB phosphorylation plays key roles in the synaptic strength, resulting in learning and memory (24) . ME treatment at 20, 100 and 500 mg/kg per d increased SYN levels in the hippocampus to 191 (SEM 15·5), 275 (SEM 23·5) and 302 (SEM 22·1) %, respectively, compared with the control group (Fig. 3(a) ). In addition, ME treatment at 20, 100 and 500 mg/kg per d increased PSD95 level in the hippocampus to 118 (SEM 14·3), 153 (SEM 13·7) and 219 (SEM 10·5) %, respectively, compared with the control group ( Fig. 3(b) ). Then, to examine the effect of ME on cholinergic function in the hippocampus, ChAT, an ACh-synthesising enzyme, expression levels were analysed, because hippocampal ACh release plays a key role during memory processing (25) . ME treatment at 100 and 500 mg/kg per d increased
ChAT level in the hippocampus to 108 (SEM 6·31) and 134 (SEM 6·22) %, respectively, compared with the control group (Fig. 3(c) ). Through activation of NGF downstream signalling, ME could enhance synaptic formation and ACh synthesisation.
Effects of Mori Fructus extract on cell differentiation, neurite outgrowth and cell proliferation in the mouse hippocampus
To evaluate the effects of ME on neuronal cell differentiation and neurite outgrowth, we performed DCX and BrdU immunohistochemistry in the mouse hippocampus. pERK and pCREB, the activated forms mediated by NGF, play an important role in cell differentiation, neurite outgrowth, cell proliferation and cell survival (26, 27) . As shown in Fig. 4(a) , ME treatment at 100 and 500 mg/kg per d increased DCX-positive cells in the DG of the hippocampus to 165 (SEM 10·4) and 172 (SEM 13·5 ) %, respectively, compared with the control group. ME also promoted neurite outgrowth of DCX-positive neurons in the DG to 144 (SEM 1·35) and 164 (SEM 2·57 ) % at 100 and 500 mg/kg per d, respectively, compared with the control group (Fig. 4(b) ). Then, we analysed the BrdU-positive cells in the DG of the hippocampus to investigate whether the effect of ME resulted in neuronal cell proliferation. As shown in Fig. 5 , ME treatment at 100 and 500 mg/kg per d increased BrdU-positive cells in the DG to 139 (SEM 10·8) and 149 (SEM 10·5) %, respectively, compared with the control group. Therefore, ME treatment enhanced neuronal cell survival by differentiation, neurite growth and proliferation of cells in the hippocampus.
Effect of Mori Fructus extract on learning and memory enhancement in mice
To evaluate the effects of ME on learning and memory enhancement, a passive avoidance test and an object recog- nition test were performed, and the retention latency period and novel object recognition time of the mice were analysed as behavioural differences, respectively. The mean retention time of the 100 and 500 mg/kg per d ME-treated groups were 378 (SEM 33·8) and 387 (SEM 33·4) s, respectively, which were significantly longer than that of the control group (207 (SEM 15·8 ) s), whereas the latency time of all groups for the acquisition trial was similar ( Fig. 6(a) ). In the object recognition test, rodents typically prefer novel or moved objects by exploring then for more time compared with familiar objects (28) . Mice fed 100 and 500 mg/kg ME spent more time on novel objects than the control during the test session by 65·3 (SEM 4·64) and 73·4 (SEM 2·92) %, respectively, whereas they spent a similar time on two familiar objects ( Fig. 6(b) ). The result suggests that ME improves learning and memory in mice. 
Discussion
In the present study, the NGF-inducing effect of ME and its downstream pathway, phosphorylation of ERK and CREB, were investigated in a mouse model. More specifically, ME promoted NGF-mediated functions such as hippocampal synapse formation, cell differentiation, neurite outgrowth and cell proliferation, resulting in memory enhancement. First, to determine whether ME acts as an NGF inducer, we measured NGF content in the mouse hippocampus. ME induced NGF production in a dose-dependent manner after treatment at 100 and 500 mg/kg per d for 7 d (Fig. 1) . Therefore, we measured pERK and pCREB expression levels, both of which are related to NGF induction. NGF is mainly mediated by a high-affinity tyrosine kinase A receptor, which acts as a docking site for various active downstream signalling and adaptive proteins (29) . The distinguishing feature of the NGF signalling pathway is activation of the mitogen-activated protein kinase pathway, which induces continuous ERK activity. In addition, ERK activation induces the nuclear translocation and nuclear activation of ribosomal S6 kinase 2 (RSK2), which in turn phosphorylates CREB to stimulate cyclic AMP response element-dependent transcription (30) . The activation of transcription factors regulates NGF-inducible gene regulation, resulting in NGF-induced neurite formation, memory formation and neurogenesis (24, 31) . In the present study, ME treatment activated ERK and CREB by phosphorylation, together with induction of NGF in the mouse hippocampus (Fig. 2) . These results indicate that ME possesses NGF-inducing activities and phosphorylates ERK and CREB in mice. Next, to investigate whether ME affects synapse formation and ACh synthesisation, we measured the expression of SYN, PSD95 and ChAT as pre-and post-synaptic markers and ACh-synthesising enzyme, respectively, in the mouse hippocampus. CREB is known to influence memory by modulating new synapses and the restructuring of existing synapses. SYN is the most abundant integral synaptic vesicle protein (3) , and PSD95 is a neuronal PSD95/discs-large/zonula occludens-1 (PDZ) protein that associates with receptors and cytoskeletal elements at synapses (32) . ChAT is an enzyme that results in the formation of ACh (33) . Therefore, these are frequently used to quantify synapses. In the present study, ME increased the expression levels of SYN, PSD95 and ChAT, suggesting enhancement of synapse formation and ACh synthesisation mediated by elevated NGF levels (Fig. 3) . Several synaptic proteins have been investigated with regard to their potential importance when lost or deficient in dementia, and synapse formation is related to memory formation and enhancement (34) . The above results suggest that ME exhibits a memory-enhancing effect mediated by synapse formation through the NGF -ERK -CREB pathway.
Finally, to determine whether ME influenced cell survival and function, we quantified newly generated cells and neurite outgrowth in the DG of the hippocampus by DCX and BrdU staining. NGF increases the number of newly generated cells and promotes cell survival and memory enhancement (21, 35) . DCX is a microtubule-associated protein that is specifically expressed in virtually all migrating neuronal precursors in the central nervous system, and is correlated with cellular proliferation and dendritic growth of newly generated neurons in the DG (36, 37) . In the present study, ME increased both the number of DCX-positive cells and neurite outgrowth in the DG of the hippocampus (Fig. 4) . Furthermore, because BrdU is a synthetic nucleoside that is commonly used to detect proliferating cells, BrdU-incorporating cells were quantified to investigate cell proliferation. ME treatment increased the number of BrdU-positive cells in the DG of the hippocampus (Fig. 5) . The production of newly generated cells in the DG of the hippocampus has been suggested to enhance memory (35) . Thus, the effects of ME on learning and memory enhancement were investigated, and we found that ME significantly prolonged the retention time and novel object recognition time, indicating enhancement of learning and memory (Fig. 6) . Taken together, these findings showed that subchronic administration of ME markedly increased the level of NGF and the expression of pERK and pCREB, suggesting that the NGF-ERK -CREB signalling pathway plays an important role in cell synapse formation, differentiation, neurite outgrowth and memory enhancement.
NGF is a possible target for therapeutics intended to improve learning, memory and general cognitive ability, and has been successfully applied in neurodegenerative diseases such as Alzheimer's disease. Therefore, there have been many attempts to find NGF inducers from natural sources, because direct application of NGF is problematic. Moreover, phytochemical-rich fruits have been reported to reverse agerelated memory impairment via an NGF-related mechanism. For example, strawberry and blueberry extracts exerted positive effects on memory and learning via up-regulation of NGF-related genes, such as ERK and CREB, in the hippocampus (11, 38, 39) . Such neuronal signalling modulation has been linked to their flavonoid phytoconstituents (11) . Flavonoids, such as hesperetin, epicatechin, epigallocatechin and fisetin, have also been shown to activate ERK and CREB signalling (38,40 -42) , which is regulated by NGF expression (43) . As is the case for other phytochemical-rich plants, Mori Fructus and its phytoconstituents appeared to modulate NGF and NGF-inducible genes, resulting in improvement of memory. However, cognitive function could be dependent on increased cerebral blood flow, known to be caused also by certain polyphenols such as resveratrol (44) and other complicated conditions such as stress and ageing (45) . Thus, further investigation is necessary to fully understand not only toxicity, pharmacokinetics and metabolism of ME, but also functional phytoconstituents.
In summary, ME induced NGF release and increased the levels of pERK and pCREB. Through this regulation, it enhanced the functioning of neurons and increased synapse formation, ACh synthesisation, neuronal cell differentiation, neurite outgrowth, cell proliferation and cognition (Fig. 7) .
